JavaScript Required

This application requires JavaScript to function properly.

Please enable JavaScript in your browser settings and reload the page.

Kamila Cisak

Assoc Professor Term

School of Medicine

Orcid identifier0000-0002-9451-0321

Assoc Professor Term
School of Medicine

kamila.cisak@louisville.edu

https://uoflhealth.org/provihttps://uoflhealth.org/provider/kamila-cisak-medical-oncology/der/kamila-cisak-medical-oncology/

SPONSORED PROJECTS

Research/Translational Research

SPONSORED PROJECTS

Showing page 1 out of 1

sort by:

Showing page 1, sponsored projects 1 to 4 of 4

sort by:

GRANT

A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults with Chronic Primary Immune Thrombocytopenia

PPD Clinical Research Services_PCR (SPN-000559)1 Jan 2026 - 31 Dec 2031

GRANT

AWD-00000223 | TAK-079-3002: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia

PPD Clinical Research Services_PCR (SPN-000559)1 Jan 2025 - 31 Dec 2030

GRANT

210882|PRN1008-018 - A Phase 3, MC, R PG Study w an OL Extension to Eval the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults & Adolescents w Persistent or Chronic Immune Thrombocytopenia (ITP)

Medpace Inc_MPI1 Jan 2021

GRANT

201026|UCB-TP0003-A Phase 3, MultiCenter, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants with Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Parexel International Corporation_PIC1 Jan 2020